Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

Pipeline problems are increasing the urge to merge

Nature Reviews Drug Discovery volume 5, pages 977–979 (2006)Cite this article

Abstract

Firms are increasingly looking to acquisitions to fill technology and product gaps.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Industry's woes.
Figure 2: Stock value of top 10 pharmaceutical companies.
Authors
  1. Simon Frantz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frantz, S. Pipeline problems are increasing the urge to merge. Nat Rev Drug Discov 5, 977–979 (2006). https://doi.org/10.1038/nrd2206

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd2206

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing